Latest bloating Stories

Research: Effect on gastric function and symptoms of drinking wine, black tea, or schnapps with a Swiss cheese fondue: Randomized controlled crossover trialPeople can be reassured that while alcohol may slow down digestion after a rich calorific meal, enjoyed by many during the Christmas season, it will not cause indigestion symptoms such as heartburn, belching and bloating, finds research in the Christmas issue published on bmj.com today.In order to determine the effects of alcohol on the...

Not Easily Identifiable, Many People Suffering from IBS Simply Don't Know Beltsville, MD (Vocus) December 8, 2010 In today's world of quick fixes and fad diets, successfully treating a chronic condition has become significantly more difficult. Irritable Bowel Syndrome affects between 15 and 20 percent of all adults in the Western world. However, IBS is difficult to identify due to the numerous symptoms associated with it. Almost 40 percent of IBS sufferers report symptoms severe and...

LEEDS, West Yorkshire, England, Oct. 28 /PRNewswire/ -- It is estimated that up to 12 million people are living with food intolerance and spending on average up to 350 pounds Sterling on wasted remedies and pills trying to relieve the symptoms before they discover the cause. By using a convenient home test kit and service such as the YorkTest, sufferers can put a stop to their food intolerance once and for all. YorkTest Laboratories is Europe's leading food allergy testing company and...

Low-fructose diet is an effective treatmentFructose intolerance, or fructose malabsorption, is common in children with recurrent or functional abdominal pain, but the condition can be effectively managed with a low"fructose diet, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.The study, "Fructose Intolerance/Malabsorption and Recurrent Abdominal Pain in Children,"...

GOTHENBURG, Sweden, October 12, 2010 /PRNewswire/ -- Albireo today announced positive top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement for patients treated with A3309 compared to placebo-treated patients. A3309...

HOUSTON, Sept. 21 /PRNewswire/ -- The popular nutraceutical health supplement, Oxy-Powder® has passed clinical trials for Irritable Bowel Syndrome (IBS) with a 99.9 percent success rate. According to the NIH, approximately 20% of Americans suffer from the symptoms of IBS, which qualifies it as one of the most common medical problems in the United States. Due to the amorphous nature of the condition, it has proven exceptionally difficult to treat. Human Clinical Trials conducted earlier...

GAITHERSBURG, Md., Aug. 16 /PRNewswire-USNewswire/ -- New data show that VSL#3, a high-potency probiotic medical food, provides effective dietary management of children affected with irritable bowel syndrome (IBS). Until recently, little has been done to understand the role of probiotics in the dietary management of children with IBS. Now, data is available showing VSL#3 as an option for children suffering from this disorder. These data were published in the July issue of the Journal of...

CABOT, Vt., June 15/PRNewswire/ -- Nearly 50 million Americans suffer from lactose intolerance* - the inability to digest lactose, a sugar found in many milk products that often leads to painful stomach cramps, bloating and other discomfort. With so many people affected by lactose intolerance, and in recognition of June as National Dairy Month, the Farm Family owners of Cabot Creamery Cooperative are offering two free webinars to help lactose intolerance sufferers cope with the effects of...

SAN DIEGO, June 3 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial...

PRINCETON, N.J., May 19 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects...